Paragon's hub-and-spoke biotech model yields another reverse merger
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Cameron Turtle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Check out this week’s medical marketing news, people on the move and industry chatter.
The biotech focused on novel antibody therapies will now be called Spyre Therapeutics, as part of a rebrand to expand its inflammatory bowel disease pipeline.
(RTTNews) - Aeglea BioTherapeutics, Inc. (AGLE) announced its name change to Spyre Therapeutics, Inc. Effective as of market open on November 28, ...
/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (Nasdaq: AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the...